METHOD AND SYSTEM FOR NONINVASIVE MASTOPEXY
First Claim
1. An ultrasound system configured for noninvasive mastopexy comprising:
- a control system configured for control of said ultrasound treatment system;
an imaging system coupled to said control system, said imaging system configured for imaging of a region of interest, said region of interest comprising of a Cooper'"'"'s ligament;
an ultrasound probe configured for generating a conformal lesion within said region of interest to facilitate mastopexy, said control system and said probe being configured to operate in a frequency range of about 1 MHz to about 15 MHz.
1 Assignment
0 Petitions
Accused Products
Abstract
Methods and systems for noninvasive mastopexy through deep tissue tightening with ultrasound are provided. An exemplary method and system comprise a therapeutic ultrasound system configured for providing ultrasound treatment to a deep tissue region, such as a region comprising muscular fascia and ligaments. In accordance with various exemplary embodiments, a therapeutic ultrasound system can be configured to achieve depth from 1 mm to 4 cm with a conformal selective deposition of ultrasound energy without damaging an intervening tissue in the range of frequencies from 1 to 15 MHz. In addition, a therapeutic ultrasound can also be configured in combination with ultrasound imaging or imaging/monitoring capabilities, either separately configured with imaging, therapy and monitoring systems or any level of integration thereof.
-
Citations
24 Claims
-
1. An ultrasound system configured for noninvasive mastopexy comprising:
-
a control system configured for control of said ultrasound treatment system;
an imaging system coupled to said control system, said imaging system configured for imaging of a region of interest, said region of interest comprising of a Cooper'"'"'s ligament;
an ultrasound probe configured for generating a conformal lesion within said region of interest to facilitate mastopexy, said control system and said probe being configured to operate in a frequency range of about 1 MHz to about 15 MHz. - View Dependent Claims (2, 5, 6, 7, 8, 9, 10, 11, 12)
-
- 4. The ultrasound system of claim 4, wherein said temporal control comprises selection of one or more temporal parameters comprising drive amplitude levels, frequency/waveforms, and timing sequences.
-
13. A method for noninvasive mastopexy, said method comprising:
-
selecting a probe configuration based on a spatial and a temporal parameter;
imaging a treatment region comprising at least one of a deep tissue region comprising at least one of muscular fascia, a ligament and a Cooper'"'"'s ligament;
verifying said temporal and said spatial parameters of said probe;
confirming acoustic coupling of said probe to said treatment region; and
applying ultrasound energy to ablate a portion of said treatment region to facilitate mastopexy. - View Dependent Claims (14, 15, 16, 17)
-
-
18. An ultrasound system configured for noninvasive mastopexy comprising:
-
a control system configured for control of said ultrasound treatment system;
an imaging system coupled to said control system, said imaging system configured for imaging of a deep tissue region comprising at least one of muscular fascia, a ligament, and a Cooper'"'"'s ligament.
-
- 19. An ultrasound probe configured for generating a conformal lesion within said region of interest to facilitate mastopexy, said control system and said ultrasound probe being configured for spatial and temporal control to generate said conformal lesion.
-
24. A method for providing noninvasive mastopexy, said method comprising:
-
localizing of at least one of a muscular fascia, a ligament, and a Cooper'"'"'s ligament within a region of interest;
targeting of delivery of ablative ultrasound energy from a transducer probe to said at least one of said muscular fascia, a ligament, and a Cooper'"'"'s ligament; and
monitoring of results of said targeted delivery area within said at least one of said muscular fascia, said ligament and said Cooper'"'"'s ligament during and after said targeted delivery to continue planning of treatment.
-
Specification